Actively Recruiting
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
Led by Dana-Farber Cancer Institute · Updated on 2025-05-20
75
Participants Needed
1
Research Sites
117 weeks
Total Duration
On this page
Sponsors
D
Dana-Farber Cancer Institute
Lead Sponsor
A
American Society of Clinical Oncology
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.
CONDITIONS
Official Title
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or older
- English speaking
- Ability to understand and willingness to sign written informed consent
- Clinical suspicion of acute leukemia
- Admitted to DFCI-affiliated inpatient unit
You will not qualify if you...
- Cognitive impairment that prevents participation in beta testing, assessed by chart review and inpatient care team consultation
- Adults unable to consent
- Individuals under 18 years old (infants, children, teenagers)
- Prisoners
- Inability to participate in in-person application testing
- Prior participation in alpha-testing through protocol 23-404
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Actively Recruiting
Research Team
A
Andrew Hantel, MD
CONTACT
E
Erin Gallagher
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here